![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accsys Technologies Plc | LSE:AXS | London | Ordinary Share | GB00BQQFX454 | ORD EUR0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.60 | 4.61% | 59.00 | 58.40 | 59.60 | 58.40 | 56.80 | 56.80 | 151,487 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Manufacturing Industries,nec | 162.02M | -69.86M | -0.3173 | -1.84 | 128.57M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/5/2007 10:14 | I have doubled my stake. | ![]() azalea | |
08/5/2007 09:37 | nice RNS today. 4 euros here we come | ![]() asparks | |
08/5/2007 09:37 | At this rate, if the EGM ratifies the deal, then 4 euros by end of month! If contracts are announced thereafter(as is likely) then who knows what price. As is often the case, my smaller purchases reap the larger rewards, ho hum; but must not grumble. | ![]() azalea | |
06/5/2007 07:58 | The EGM on the 15/5 should approve the deal between Celanese and AXS, the former to supply chemicals direct to AXS customers and to buy 5.5% of new shares in AXS, with the option to buy up to 29.9%. Approval of the deal will enhance AXS opportunities to sign up new customers/renew contracts for its patented process. | ![]() azalea | |
05/5/2007 13:46 | new to this one chaps.very happy of course like the deal a lot. especially from a save the forests point of view. what can we expect from the AGM.? am i right in think we will get a trading statement or information about new license deals . ? thank you for anyones time in advance. | ![]() sitiain | |
04/5/2007 15:43 | EGM on the 15/5; what price on the 16/5! | ![]() azalea | |
01/5/2007 12:25 | Will AXS benefit from shortage of timber as per article in today's Ft page 17? | ![]() lasata | |
30/4/2007 19:12 | Obvious shares are too cheap Could be +50 tomorrow E20 about right...........once the franchises get announced. You've got to put the production plants by the source - the forests........ | fryern | |
30/4/2007 14:39 | 3+ euros ahead as investors move in ahead of the May EGM approval of the deal with Celanese. | ![]() azalea | |
30/4/2007 13:45 | Hmm watch the extraordinay amount of trading on streaming. Small price variation but somethings generating interest as I thought . | ![]() power | |
30/4/2007 12:23 | is there something in the air on this today , somehow it feels positive ?? | ![]() power | |
26/4/2007 19:50 | Yep Cairn is an age thing........ but it sends out a great message. AXS is the future as is MGT Now I say buy AXS now and MGT at $5 Fortunately I have mine at much less. Telling guys there are 2 great companies out of the same stable (horse talk) I would hope they would appreciate my knowledge. I'm into games on TV - totally disconnected. Watch this space!!!!!!!!!!! | fryern | |
26/4/2007 18:47 | Fryern, not a moan, it was a comment. I doubt whether anyone else on this thread is remotely interested in Medicsight. Just start another thread. Full stop. Please try not to tell all again about Cairn, you've put that in writing several times already. It's probably an age thing. Whatever the outcome of the Celanese holding & option, it bodes well for AXS share price in the medium term. Also started to be tipped elsewhere as a growth stock, though it took 18 months and a near trebling of the share price for these experts to "discover" it. Ho hum... | ![]() damanko | |
26/4/2007 17:35 | Damanko Stop moaning ACCSYS TECH ORD EUR0.01 (AXS) 2.90 +0.095 (+3.39%) Go visit Berkeley Sq. Azalea Capping by contract prevents this. That's what it sounds to me. | fryern | |
26/4/2007 13:42 | Fryern If the maximum 29.9% option is exercised, the management's holdings will be significantly diluted by the issue of new shares. This could perhaps leave the related members holding less than a controlling 50.5% stake. The remainder of the management might be more ameniable to a bid if the price was right. I see absolutely no point in Celanese taking a 29.9% option without a bid in mind. | ![]() azalea | |
26/4/2007 13:22 | Fryern, as you know, so do I. But there is a time and a place. Why not start a Medicsight thread on here, and let the graph speak for itself? 2 entirely different products, markets etc. Yes, they had common ownership - ie what was STG Holdings, now McNiven & Cameron. By the way I am still waiting (18 months after the initial letter with statement of intent) - for the letter/advice from M&C offering to buy out minority shareholders. Received a short note a few months ago stating they had been "too busy" last financial year. I suspect (though of course I may be wrong) that they have already offloaded equity in Accsys. | ![]() damanko | |
26/4/2007 13:01 | Just so you all know..... MGT -- MGT Capital Investments, Inc. Com ($0.001) Address: The Kensington Centre 66 Hammersmith Road London, W14 8UT GBR AXS Extraordinary General Meeting of the Company (the "EGM") to be held on Tuesday, 15 May 2007 at the Company's offices at Kensington Centre, 66 Hammersmith Road, London W14 8UD MGT is run by Tim Paterson-Brown, AXS by brother William. Both have world beating products. Main offices of both 46 Berkeley Sq. I have interests in both. | fryern | |
26/4/2007 12:50 | Celanese will have an option to increase its ownership of Accsys to 29.9 pct in the future, the company said. Hostile bid not possible most of the the 70.1% will be in management hands/control. Worth checking. Anyhow this is a long term investment. Product has no competition - just needs more production plants..... | fryern | |
25/4/2007 18:28 | Fryern Yes I understand that - 29.9% including the 5.5%, but that would not stop Celanese then going on to make a potentially hostile bid the next week/month. AXS Board would have to be pretty stupid if it did not realise this and undoubtedly they do. At the end of the day the latter may welcome it - if the price was right! | ![]() azalea | |
25/4/2007 16:39 | Keep your eye on MGT (Medicsight Capital Investments). Glyn C Thomas money probably going there!!!! Out of the same stable. Glyn was CFO of MGT before moving across the table to AXS. Azalea it's up to a max. of 29.9% | fryern | |
25/4/2007 16:13 | azalea I would not be surprised if we reach 3 sooner than that | ![]() asparks | |
25/4/2007 13:57 | I'm looking for an share price of 3 euros by end of May - Celanese having bought £44m (8.1m - 5.5%) of new shares with the option of 29.9%. By then AXS could be following up with news of contracts. IF the 29.9% is exercised then I can only assume a bid will be in the offing! | ![]() azalea | |
24/4/2007 09:47 | The Company has received notification on 23rd April 2007 that Rajhi Holdings has increased its holding in the Company to a notifiable interest of 9,000,000 ordinary shares representing 6.4% of the total voting rights in the Company. The Company has also received notification on 23rd April 2007 that UBS Wealth Management (UK) Limited, on behalf of clients, has increased its holding in the Company to a notifiable interest of 6,156,453 ordinary shares representing 4.4% of the total voting rights in the Company. The Company also announces that on 23rd April, 2007, the following directors of Accsys dealt in the Company's ordinary shares as follows: Gordon A. Campbell purchased 50,000 ordinary shares in the Company and currently owns a total of 100,000 ordinary shares. Edward J Pratt sold 720,000 shares in the Company at a price of Euro2.77 per share and currently owns a total of 618 ordinary shares and has options over an aggregate of 1,720,000 ordinary shares. Glyn C Thomas sold 480,000 ordinary shares in the Company at a price of Euro2.77 per share and currently owns a total of 618 ordinary shares and has options over an aggregate of 1,230,000 ordinary shares. The Company had previously announced that on 29th March 2007 Edward J Pratt and Glyn C Thomas had exercised options to subscribe for the same number of ordinary shares described above at a subscription price of Euro0.46 per share. | ![]() power |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions